Massing at the Starting Line for the $1B Program Tax/Grant Program
May 22nd, 2010
No comments
Small life-sciences companies in the US will get funds in the form of tax credits or as a grant covering 50% of project development costs (for 2009 and 2010) for companies with fewer than 250 workers. The plan, part of the US healthcare overhaul approved in March, is expected to be open to hundreds of biotech, medical device and diagnostic companies that are both public and privately held. Read more…
Covidien, plc, a Dublin, Ireland medical device and pharmaceutical maker but with its U.S. headquarters in Mansfield, Mass. announced an agreement to acquire Aspect Medical Systems (ASPM) of Norwood, Mass. 
Every time the markets rebound, investors deliberate whether this marks the bottom for share pricing and if so, might it be time to get in. However, for those of us who remain skeptical; we have seen too many spikes in momentum, resistance, confidence and resilience as second quarter earnings were good but will it last? Valuations provide indicators when compared to the rapid decline and slow moves to present market levels.